Stocks
Genesco Financial Statements (GCO) |
||||||||||
| Genescosmart-lab.ru | % | 2021 | 2022 | 2023 | 2024 | 2024 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 27.05.2021 | 23.03.2022 | 22.03.2023 | 31.01.2024 | 27.03.2024 | 12.09.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 1 787 | 2 422 | 2 385 | 2 325 | 2 325 | 1 966 | |||
| Operating Income, bln rub | 42.1 | 104.4 | 51.0 | 16.8 | -13.5 | -82.9 | ||||
| EBITDA, bln rub | ? | -59.7 | 190.4 | 136.7 | 23.6 | 35.8 | -57.4 | |||
| Net profit, bln rub | ? | -56.0 | 114.9 | 71.9 | -16.8 | -16.8 | -68.7 | |||
| OCF, bln rub | ? | 157.7 | 239.9 | -164.9 | 94.8 | -6.03 | ||||
| CAPEX, bln rub | ? | 24.1 | 53.9 | 59.9 | 60.3 | 14.3 | ||||
| FCF, bln rub | ? | 133.6 | 186.0 | -224.8 | 34.5 | -20.3 | ||||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| OPEX, bln rub | 813.8 | 1 034 | 1 042 | 1 082 | 1 082 | 1 006 | ||||
| Cost of production, bln rub | 982.1 | 1 241 | 1 249 | 1 226 | 1 226 | 1 042 | ||||
| R&D, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Interest expenses, bln rub | 5.09 | 2.45 | 2.92 | 7.78 | 7.78 | 4.47 | ||||
| Assets, bln rub | 1 587 | 1 562 | 1 456 | 1 330 | 1 330 | 1 384 | ||||
| Net Assets, bln rub | ? | 566.8 | 602.5 | 607.0 | 571.2 | 571.2 | 532.6 | |||
| Debt, bln rub | 734.0 | 632.6 | 580.4 | 522.9 | 522.9 | 530.1 | ||||
| Cash, bln rub | 215.1 | 320.5 | 48.0 | 35.2 | 35.2 | 45.9 | ||||
| Net debt, bln rub | 518.9 | 312.1 | 532.4 | 487.8 | 487.8 | 484.3 | ||||
| Ordinary share price, rub | 38.8 | 62.9 | 47.8 | 27.8 | 28.8 | 27.0 | ||||
| Number of ordinary shares, mln | 14.2 | 14.2 | 12.5 | 11.2 | 11.2 | 10.9 | ||||
| Market cap, bln rub | 552 | 892 | 595 | 312 | 324 | 295 | ||||
| EV, bln rub | ? | 1 071 | 1 204 | 1 127 | 800 | 812 | 779 | |||
| Book value, bln rub | 497 | 534 | 541 | 571 | 534 | 496 | ||||
| EPS, rub | ? | -3.94 | 8.11 | 5.77 | -1.50 | -1.50 | -6.28 | |||
| FCF/share, rub | 9.40 | 13.1 | -18.0 | 0.00 | 3.07 | -1.86 | ||||
| BV/share, rub | 35.0 | 37.7 | 43.5 | 50.8 | 47.5 | 45.3 | ||||
| EBITDA margin, % | ? | -3.34% | 7.86% | 5.73% | 1.01% | 1.54% | -2.92% | |||
| Net margin, % | ? | -3.14% | 4.74% | 3.02% | -0.72% | -0.72% | -3.49% | |||
| FCF yield, % | ? | 24.2% | 20.9% | -37.8% | 0.00% | 10.6% | -6.88% | |||
| ROE, % | ? | -9.89% | 19.1% | 11.8% | -2.95% | -2.95% | -12.9% | |||
| ROA, % | ? | -3.53% | 7.35% | 4.94% | -1.27% | -1.27% | -4.96% | |||
| P/E | ? | -9.85 | 7.77 | 8.27 | -18.6 | -19.2 | -4.30 | |||
| P/FCF | 4.13 | 4.80 | -2.65 | 9.39 | -14.5 | |||||
| P/S | ? | 0.31 | 0.37 | 0.25 | 0.13 | 0.14 | 0.15 | |||
| P/BV | ? | 1.11 | 1.67 | 1.10 | 0.55 | 0.61 | 0.59 | |||
| EV/EBITDA | ? | -17.9 | 6.32 | 8.25 | 33.9 | 22.6 | -13.6 | |||
| Debt/EBITDA | -8.70 | 1.64 | 3.90 | 20.7 | 13.6 | -8.44 | ||||
| R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0.00% | 0 | |||||
| CAPEX/Revenue, % | 1.35% | 2.23% | 2.51% | 0.00% | 2.59% | 0.73% | ||||
| Genesco shareholders | ||||||||||
